Drugs News and Research

RSS

Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization

An interview with Kitty van Weezenbeek, Director of Surveillance, Prevention and Control of AMR for the World Health Organistion (WHO) AMR division.

20 Nov 2023

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the licence of the cystic fibrosis medicines Kaftrio (ivacaftor, tezacaftor and elexacaftor) and Kalydeco (ivacaftor) for children aged two to five years old.

20 Nov 2023

Groundbreaking technology developed to extract mesenchymal stem cells from pure bone marrow

Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in collaboration with the Agency for Science, Technology and Research (A*STAR) Bioprocessing Technology Institute (BTI) and National University Health System (NUHS), have developed a groundbreaking technology capable of extracting mesenchymal stem cells (MSCs) directly from pure bone marrow – also known as bone marrow aspirate (BMA), a pivotal source of MSCs – without dilution.

20 Nov 2023

Pigeon virus causes fatal neurological disease in young leukemia patient

A case report details a fatal neurologic disease in an immunocompromised toddler caused by pigeon avian paramyxovirus, underscoring the effectiveness of metagenomic testing in diagnosing complex infectious diseases.

19 Nov 2023

Study reveals surprising trends in non-diabetic adults' use of artificial sweeteners in Brazil

The study investigates the widespread use of non-nutritive sweeteners (NNS) among non-diabetic Brazilian adults, revealing that higher education, income, and BMI increase the likelihood of regular NNS consumption, challenging the perception of NNS as a healthy alternative.

19 Nov 2023

Stem-cell-derived brain cells hold promise for Alzheimer's, Parkinson's research

Researchers at the University of Wisconsin–Madison have identified a protein key to the development of a type of brain cell believed to play a role in disorders like Alzheimer's and Parkinson's diseases and used the discovery to grow the neurons from stem cells for the first time.

17 Nov 2023

Antibiotic consumption in Europe rebounds to pre-pandemic levels

This year's European Antibiotic Awareness Day (EAAD) focuses on the targets outlined in the 2023 Council Recommendation to step up efforts in the European Union (EU) against antimicrobial resistance in a One Health approach.

17 Nov 2023

New understanding of lung cancer cells' 'memories' suggests novel treatment approach

A new understanding of lung cancer cells' "memories" suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center (MSK) researchers have found.

17 Nov 2023

RIT scientist earns NIH award to support research on building the next generation of drugs

Rochester Institute of Technology's Emiliano Brini, assistant professor in the School of Chemistry and Materials Science, has received an award from the National Institutes of Health (NIH) to support his research on building the next generation of drugs.

17 Nov 2023

Unraveling the immune system's response to nanoparticle drug delivery

To reduce the side effects associated with chemotherapy treatments, researchers have investigated the use of delivery systems that can take more drugs directly to the tumor. Ninh (Irene) La-Beck, Pharm.D., from the Department of Immunotherapeutics and Biotechnology at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy is one of those researchers.

17 Nov 2023

Experts shed light on how autism affects the diagnosis, treatment of epilepsy and vice versa

Compared with the general population, epilepsy is more common in people with autism - and autism is more common in people with epilepsy. How can autism affect the diagnosis and treatment of epilepsy, and vice versa? Joy Mazur spoke to Dr. Colin Reilly and Dr. Stéphane Auvin.

17 Nov 2023

Green tea-silver nanoparticles: A promising weapon against superbugs

Once upon a time, people believed to be invincible against bacterial diseases, thanks to the antibiotics. Does this sound like a fairy tale? By all means! Nothing could be further from the truth.

17 Nov 2023

CMA clarifies cooperation on combination therapies to speed up patient access to vital treatments

The Competition and Markets Authority (CMA) has today issued a statement clarifying that certain types of engagements between competing drug firms working on 'combination therapies' will not be prioritized for investigation - making it easier for drug firms to work together to develop vital treatments for use in the NHS.

17 Nov 2023

New study provides comprehensive picture of perioperative cardiac arrest in the UK

A new study ‒ that has examined all cardiac arrests occurring during or soon after surgery in more than 300 UK hospitals over a one-year period ‒ has identified that this extremely dangerous and often fatal event occurs in 3 per 10,000 surgeries requiring anesthesia.

16 Nov 2023

UTS researcher tests new handheld device for rapidly and accurately identifying drug specimens

University of Technology Sydney (UTS) Centre for Forensic Science PhD candidate Harry Fursman is working on two fronts to prevent harm to people who use drugs: He is testing a new handheld device for rapidly and accurately identifying drug specimens and conducting ongoing chemical analysis of used syringes.

16 Nov 2023

Promising new cancer therapy appears to be extremely potent against tuberculosis

A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).

16 Nov 2023

Insulin manufacturers extend market exclusivity through additional patents, study finds

Over the last four decades, insulin manufacturers have extended their periods of market exclusivity on brand-name insulin products by employing several strategies, including filing additional patents on their products after FDA approval and obtaining many patents on delivery devices for their insulin products.

16 Nov 2023

Drugs News and Research

Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

Groundbreaking technology developed to extract mesenchymal stem cells from pure bone marrow

Pigeon virus causes fatal neurological disease in young leukemia patient

Study reveals surprising trends in non-diabetic adults' use of artificial sweeteners in Brazil

Stem-cell-derived brain cells hold promise for Alzheimer's, Parkinson's research

Antibiotic consumption in Europe rebounds to pre-pandemic levels

New understanding of lung cancer cells' 'memories' suggests novel treatment approach

RIT scientist earns NIH award to support research on building the next generation of drugs

Unraveling the immune system's response to nanoparticle drug delivery

Experts shed light on how autism affects the diagnosis, treatment of epilepsy and vice versa

Green tea-silver nanoparticles: A promising weapon against superbugs

CMA clarifies cooperation on combination therapies to speed up patient access to vital treatments

New study provides comprehensive picture of perioperative cardiac arrest in the UK

UTS researcher tests new handheld device for rapidly and accurately identifying drug specimens

Promising new cancer therapy appears to be extremely potent against tuberculosis

Insulin manufacturers extend market exclusivity through additional patents, study finds

Landmark studies present new era for bladder cancer treatment

TACTIC project aims to uncover genetic causes of cancer and develop targeted therapies

Exploring the dual role of nirmatrelvir and bisphosphonates in COVID-19 treatment and immunity

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News